AGP Picks
View all

Samoa Wellness Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Samoa Wellness Report.

Press releases published on September 14, 2026

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
PetMeds Appoints Andrew Parry as Chief Technology Officer
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications
Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
Neutra Corp's Neutra Life Sciences Expands 2026 Industry Conference Schedule to Deepen Sponsor and CRO Relationships Across Its Site Network
CAPHRA announces the Asia-Pacific Declaration call for Safer Nicotine Access
Citizens Commission on Human Rights International: Dr. Thomas Szasz’s Warning Against Involuntary Hospitalization Is Now UN Human-Rights Doctrine
Choice MedWaste Expands Regional Healthcare Infrastructure with New Autoclave Medical Waste Treatment Facility
Inspire Expands Women’s Health Support With New PMOS and Postpartum Health Communities
Fifty years after landmark IL-2 discovery, Global Virus Network reflects on a breakthrough that transformed medicine
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
Quiet Communities and Science for Georgia Release First-of-its-Kind Study on the Impacts of Data Center and Cryptomining Noise
KFSH Riyadh Records Zero High-Risk Findings Across Nearly 1,800 Measures in JCI Reaccreditation
GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF
GENFIT engage un programme de développement clinique de phase 2 avec Nangibotide dans l’ACLF

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Samoa Wellness Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.